ATG7 is an essential regulator of autophagy, a process involved in tumor suppression, maintenance of the stemness properties of cancer cells, disease recurrence, and anticancer drug resistance, and ATG7 upregulation in recipient cells induces resistance to erlotinib [57,59]. This evidence concerns the gene ATG7 and neoplasm.